Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Can CureVac Recover After Its Vaccine Setback?

TheMotleyFool

0 0

Can CureVac Recover After Its Vaccine Setback?

Many investors thought CureVac (NASDAQ: CVAC) would be the next to market with an mRNA vaccine. And soon. But the vaccine candidate's future looks uncertain after a recent trial report. In this Motley Fool Live video recorded on June 22, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss CureVac's phase 3 data report -- and what it means for the company's future in the coronavirus vaccine space.

Source Fool.com

Like: 0

CVAC

Teilen